MARIA GROTZ: Open Payments
NPI 1972634806 · ORLEANS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 15 payments from 9 companies in 2025. Trend: 2023 $1,317 · 2024 $1,552 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $419 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $142 |
| ABBVIE INC. | 1 | $137 |
| Gilead Sciences, Inc. | 1 | $130 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Neurocrine BioSciences, Inc. | 2 | $72 |
Products named: Auvelity, CAPLYTA, VRAYLAR, Epclusa, REXULTI, INVEGA SUSTENNA, COBENFY, TZIELD.
Industry payments across MA — which companies pay providers there.
